Ovarian hyperstimulation syndrome;Das ovarielle überstimulationssyndrom

Gynakologe

Volumn 35, Issue 4, 2002, Pages 363-371

  Schubert, J ^a   Merz, M ^a   Distler, W ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

In vitro fertilization; Ovarian hyperstimulation syndrome; Reproductive medicine; Stimulation therapy

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; GONADOTROPIN;

ARTICLE; FEMALE; FERTILIZATION IN VITRO; GERMANY; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; OOCYTE MATURATION; OVARY HYPERSTIMULATION; OVULATION INDUCTION; REGISTER; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; THROMBOSIS PREVENTION;

EID: 0036939773     PISSN: 00175994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00129-002-1174-8     Document Type: Article

References (64)

1. Aboulghar MA, Mansour RT, Serour GI, Amin Y (1990) Ultrasonically guided vaginal aspiration of ascites in the treatment of severe ovarian hyperstimulation syndrome. Fertil Steril 53: 933-935
2. Abramov Y, Schenker JG, Lewin A, Friedler S, Nisman B, Barak V (1996) Plasma inflammatory cytokines correlate to the ovarian hyperstimulation syndrome. Hum Reprod 11: 1381-1386
3. Abulafia O, Sherer DM (2000) Angiogenesis in the ovary. J Obstet Gynecol 182: 240-246
4. Al-Inany H, Aboulgar MA, Evers JLH (2000) Human albumin administration for the prevention of severe OHSS. Middle East Fertil Soc J 5: 157-161
5. Asch R, Ivery G, Goldsman M (1993) The use of intravenous albumin in patients at high risk for severe ovarian hyperstimulation syndrome. Hum Reprod 8: 1015-1020
6. Aurousseau MH, Samana MM, Belhassen A, Herve F, Hugues JN (1995) Risk of thromboembolism in relation to an in-vitro fertilization programme: three case reports Hum Reprod 10: 94-97
7. Ayhan A, Tuncer ZS, Aksu AT (1996) Ovarian hyperstimulation syndrome associated with spontaneous pregnancy. Hum Reprod 11: 1600-1601
8. Balasch J, Carmona F, Llach J, Arroyo V, Jove I, Vanrell JA (1990) Acute prerenal failure and liver dysfunction in a patient with severe ovarian hyperstimulation syndrome. Hum Reprod 5: 348-353
9. Balasch J, Reverter JC, Fabregues F, Tassies D, Ordinas A, Vanrell JA (1996) Increased induced monocyte tissue factor expression by plasma from patients with severe ovarian hyperstimulation syndrome. Fertil Steril 66: 608-613
10. Borgaonkar MR, Marshall JK (1999) Marked elevation of serum transaminases may be associated with ovarian hyperstimulation syndrome. Am J Gastroenterol 94: 3373
11. Brinsden PR, Wada I, Tan SL, Balen A, Jacobs HS (1995) Diagnosis, prevention and management of ovarian hyperstimulation syndrome. Br J Obstet Gynecol 102: 767-772
12. 2+ and von Willebrand factor release in human endothelial cells. Am J Pathol 138: 213-221
13. Chow KK, Choo HT (1984) Ovarian hyperstimulation syndrome with clomiphene citrat. Case report. Br J Obstet Gynecol 91: 1051-1052
14. Claus M, Gerlach M, Gerlach H et al. (1990) Vascular permeability factor: a tumor derived polypeptide that induces endothelial cell and monocyte procoagulant activity and promotes monocyte migration. J Exp Med 172: 1535-1545
15. Deutsche Gesellschaft für Gynäkologie und Geburtshilfe et al. (2001) Deutsches IVF-Register 2000
16. Delbaere A, Bergmann PJM, Englert Y (1997) Features of the renin-angiotensin system in ascites and pleural effusion during severe ovarian hyperstimulation syndrome. J Assist Reprod Genet 14: 241-244
17. Enskog A, Henriksson M, Unander M, Nilsson L, Brannstrom M (1999) Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril 71: 808-814
18. Evbumwan IO, Davidson JM, Murdoch AP (2000) Coexistent hemoconcentration and hypoosmolality during superovulation and in severe ovarian hyperstimulation syndrome: A volume homeostasis paradox. Fertil Steril 74: 67-72
19. Fukaya T, Chida S, Terada Y, Funayama Y, Yajima A (1993) Treatment of severe ovarian hyperstimulation syndrome by ultrafiltration and reinfusion of ascity fluid. Fertil Steril 61: 561-564
20. Geva E, Jaffe RB (2000) Role ofthe vascular endothelial growth factor in ovarian physiology and pathology. Fertil Steril 74: 429-438
21. Golan A, Ron-el R, Herman A, Soffer Y, Weinraub Z, Caspi E (1989) Ovarian hyperstimulation syndrome: an update review. Obstst Gynecol Surv 44: 430-440
22. Hulinsky I, Smith HC (1995) External jugular vein thrombosis: a complication of the ovarian hyperstimulation syndrome. Med J Aus 162:102-103
23. Iwabe T, Harada T, Tuzaki T, Terakawa N (1994) Laparoscopic unwinding of adnexal torsion caused by ovarian hyperstimulation syndrome. Hum Reprod 9: 2350-2352
24. Ito M, Harada T, Iwabe T, Tanikawa M, Terakawa N (2000) Cytokine levels in a patient with severe ovarian hyperstimulation syndrome before and after the ultrafiltration and reinfusion ofascitic fiuid. J Assist Reprod Genet 17: 118-120
25. Knox GE (1974) Antihistamine blockade of the ovarian hyperstimulation syndrome. Am J Obstet Gynecol 118: 992-994
26. Kodama H, Fukuda J, Karube H, Matsui T, Shimitsu Y, Tanaka T (1995) Characteristic of blood hemostatic markers in a patient with ovarian hyperstimulation syndrome who actually developed thromboembolism. Fertil Steril 64: 1207-1209
27. Kodama H, Fukuda J, Karube H, Matsui T, Shimitsu Y, Tanaka T (1996) Status of the coagulation and fibrinolytic systems in ovarian hyperstimulation syndrome. Fertil Steril 66: 417-424
28. Koike T, Araki S, Minakami H, Ogawa S, Sayama M, Shibahara H, Sato I (2000) Clinical efficacy of peritoneovenous shunting for the treatment of severe ovarian hyperstimulation syndrome. Hum Reprod 15: 113-117
29. Lamon D, Chang CK, Hruska L, Kerlakian G, Smith JM (2000) Superior vena cava thrombosis after in vitro fertilization: Case report and review of the literature. Ann Vasc Surg 14: 283-285
30. Levin ER, Rosen GF, Cassidenti DL et al. (1998) Role of vascular endothelial cell growth factor in ovarian hyperstimulation syndrome. J Clin Invest 102: 1978-1985
31. Lightman A, Tarlatzis BC, Rzasa PJ et al. (1987) The ovarian renin-angiotensin system: renin-like activity and angiotensin II/Ill immunoreactivity in gonadotropin-stimulated and unstimulated human follicular fluid. Am J Obstet Gynecol 156: 808-816
32. Lindner C, Braendle W, Kohler S, Bettendorf G (1989) Vermehrte Häufigkeit des ovariellen Überstimulationssyndroms nach GnRH-Analoga/HMG Therapie. Geburtsh Frauenheilk 49: 337-344
33. Ludwig M, Bauer O, Diedrich K (1997) Überblick über das ovarielle Überstimulationssyndrom: ein reproduktionsmedizinisch-iatrogenes Krankheitsbild mit internistischer Konsequenz. Wien Med Wochenschr 147: 516-527
34. Ludwig M, Felberbaum RE, Devroey P et al. (2000) Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide®) in controlled ovarian stimulation for assisted reproduction. Arch Gynecol Obstet 264: 29-32
35. Lyons CA, Wheeler CA, Frishman GN, Hackett RJ, Seifer DB, Haning RV (1994) Early and late presentation of the ovarian hyperstimulation syndrome: two distinct entities with different risk factors. Hum Reprod 9: 792-799
36. Mathur RS, Akande AV, Keay SD, Hunt LP, Jenkins JM (2000) Distinction between early and late ovarian hyperstimulation syndrome. Fertil Steril 73: 901-907
37. Mills MS, Eddowes HA, Fox R, Wardle G (1992) Subclavian vein thrombosis: a late complication of ovarian hyperstimulation syndrome. Hum Reprod 7: 778-783
38. Morris RS, Miller C, Jacobs L, Miller K (1995) Conservative management of ovarian hyperstimulation syndrome. J Reprod Med 40: 711-714
39. Morris RS, Wong IL, Kirkman E, Gentschein E, Paulson RJ (1995) Inhibition of ovarian-derived prorenin to angiotensin cascade in the treatment of ovarian hyperstimulation syndrome. Hum Reprod 10: 1355-1358
40. Navot D, Bergh PA, Laufer N (1992) Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril 58: 249-261
41. Navot D, Margaliot EJ, Laufer N et al. (1987) Direct correlation between plasma renin activity and severity of the ovarian hyperstimulation syndrome. Fertil Steril 48: 57-61
42. Neulen J, Yan Z, Raczek S et al. (1995) Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome. J Clin Endocrinol Metab 80: 1967-1971
43. Ong AC, Eisen V, Rennie DP et al. (1991) The pathogenesis of the ovarian hyperstimulation syndrome (OHS): a possible role for ovarian renin. Clin Endocrinol (Oxf) 34: 43-49
44. Padilla SL, Zamaria S, Baramki TA, Garcia JE (1990) Abdominal paracentesis for the ovarian hyperstimulation syndrome with severe pulmonary compromise. Fertil Steril 53: 365-367
45. Paulson RJ, Do YS, Hsueh WA, Eggena P, Lobo RA (1989) Ovarian renin production in vitro and in vivo: characterization and clinical correlation. Fertil Steril 51: 634-638
46. Phillips EL, Gladstone W, van de Wiele R (1975) Studies of the coagulation and fibrinolytic systems in hyperstimulation syndrome after the administration of human gonadotropin. J Reprod Med 14: 138-143
47. Rabinerson D, Shalev J, Royburt M, Ben-Raffael Z, Dekel A (2000) Severe unilateral hydrothorax as the only manifestation of the ovarian hyperstimulation syndrome. Gynecol Obstet Invest 49: 140-142
48. Rizk B, Meagher S, Fischer AM (1990) Severe ovarian hyperstimulation syndrome and cerebrovascular accidents. Hum Reprod 5: 697-698
49. Roden S, Juvin K, Homasson JP, Israel-Biet D (2000) An uncommon etiology of pleural effusion: The ovarian hyperstimulation syndrome. Chest 118: 256-258
50. Ryley NG, Forman R, Brlow D, Fleming KA, Trowell JM (1990) Liver abnormality in ovarian hyperstimulation Syndrome. Hum Reprod 5: 938-943
51. Schanzer A, Rockman CB, Jacobowitz GR, Riles TS (2000) Internal jugular vein thrombosis in association with the ovarian hyperstimulation syndrome. J Vasc Surg 31: 815-818
52. Schenker JG, Ezra Y (1994) Complications of assisted reproductive techniques. Fertil Steril 61: 411-422
53. Schenker JG, Polishuk WZ (1976) The role of prostaglandins in ovarian hyperstimulation syndrome. Eur J Obstet Gynecol Reprod Biol 6: 47-52
54. Sealey JE, Glorioso N, Itskovitz J, Laragh JH (1986) Prorenin as a reproductive hormone. New form of the renin system. Am J Med 81: 1041-1046
55. Semba S, Moriya T, Youssef EM, Sasano H (2000) An autopsy case of ovarian hyperstimulation syndrome with massive pulmonary edema and pleural effusion. Pathol Int 50: 549-552
56. Shigematsu T, Kubota E, Aman M (2000) Adult respiratory distress syndrome as a manifestation of ovarian hyperstimulation syndrome. Int J Gynecol Obstet 69: 169-170
57. Tang OS, Ng EHY, Cheng PW, Ho PC (2000) Cortical vein thrombosis misinterpreted as intracranial haemorrhage in severe ovarian hyperstimulation syndrome. Hum Reprod 15:1913-1916
58. Todorow S, Schricker ST, Siebzehnrübl ER, Neidhardt B, Wildt L, Lang N (1993) Von Willebrand Factor: an endothelial marker to monitor in-vitro fertilization patients with ovarian hyperstimulation syndrome. Hum Reprod 8: 2039-2046
59. Vrtovec HM, Tomazevic T (1995) Preventing severe ovarian hyperstimulation syndrome in an in vitro fertilization/embryo transfer program. Use of follicular aspiration after human chorionic gonadotropin administration. J Reprod Med 40: 37-40
60. Waterstone JJ, Summers BA, Hoskins MC, Berry J, Parsons JH (1992) Ovarian hyperstimulation syndrome and deep cerebral venous thrombosis. Br J Obstet Gynecol 99: 439-440
61. Whelan III JG, Vlahos NF (2000) The ovarian hyperstimulation syndrome. Fertil Steril 73: 883-896
62. Willms AB, Schlund JF, Meyer WR (1995) Endovaginal doppler ultrasound in ovarian torsion: a case series. Ultrasound Obstet Gynecol 5: 129-132
63. Yan Z, Weich HA, Bernart W, Breckwoldt M, Neulen J (1993) Vascular endothelial growth factor (VEGF) messenger ribonucleic acid (mRNA) expression in luteinized human granulosa cells in vitro. J Clin Endocrinol Metab 77: 1723-1725
64. Zosmer A, Katz Z, Lancet M, Konichetzky S, Schwarz-Shoham Z (1987) Adult respiratory distress syndrome complicating ovarian hyperstimulation syndrome. Fertil Steril 47: 524-526